T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy

SIMPLE SUMMARY: The ultimate goal of T cell-engaging immunotherapy is to endorse the activity of a person’s own cytotoxic T cells in the tumor microenvironment, finally destroying cancer cells. Several types of immunotherapy are either approved for use or are under study in clinical trials to determ...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bousser, Elien, Callewaert, Nico, Festjens, Nele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657024/
https://www.ncbi.nlm.nih.gov/pubmed/34885176
http://dx.doi.org/10.3390/cancers13236067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657024/
https://www.ncbi.nlm.nih.gov/pubmed/34885176
http://dx.doi.org/10.3390/cancers13236067

Ejemplares similares